Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Retinal Degeneration 3 (RD3) Peptid

RD3 Reaktivität: Säugetier Wirt: Synthetic BP, WB, IHC
Produktnummer ABIN938889

Kurzübersicht für Retinal Degeneration 3 (RD3) Peptid (ABIN938889)

Target

RD3 (Retinal Degeneration 3 (RD3))

Spezies

Säugetier

Quelle

  • 1
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Protein-Typ

    Synthetic

    Sequenz

    GQMREAERQQ RERSNAVRKV CTGVDYSWLA STPRSTYDLS PIERLQLEDV

    Produktmerkmale

    A synthetic peptide for use as a blocking control in assays to test for specificity of RD3 antibody,
    Alternative Names: RD3 control peptide, RD3 antibody Blocking Peptide, Anti-RD3 Blocking Peptide, Retinal Degeneration 3 Blocking Peptide, C1orf36 Blocking Peptide, LCA12 Blocking Peptide, RD3, RD-3, RD 3, RD-3 Blocking Peptide, RD 3 Blocking Peptide
  • Applikationshinweise

    Optimal conditions should be determined by the investigator

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handhabung

    Avoid repeated freeze/thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20 °C long term.
  • Target

    RD3 (Retinal Degeneration 3 (RD3))

    Hintergrund

    RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).

    Molekulargewicht

    23 kDa
Sie sind hier:
Chat with us!